FDA approval of metformin for diabetes does not mean FDA approval for longevity use - those are distinct regulatory determinations, and the longevity indication is off-label
It alters the colour of the iris and may distort the shape of the pupil
A recent study was performed to explore the global methylation profile of fetal heart DNA from 22 medically terminated pregnancies (4 with normal development, 6 with DS-CHD, 6 with DS without CHD, and 6 with isolated CHD) in comparison to blood DNA from 656 subjects (Serra-Juh et al., 2015)
Less Common but Serious Side Effects Some less common but more serious GLP-1 side effects are worth being aware of: Pancreatitis (inflammation of the pancreas) Gallbladder problems (including gallstones) Acute kidney injury (usually as a result of severe dehydration from vomiting or diarrhea) Diabetic retinopathy worsening (particularly in patients with rapid improvement in blood sugar control) Hypoglycemia (when combined with other diabetes medications like sulfonylureas or insulin) All GLP-1 medications also carry a warning regarding a theoretical risk of medullary thyroid carcinoma, based on animal studies
Is there support available for ensuring product labels meet regulatory requirements
Food and Drug Administration (FDA) approves the use of semaglutide for weight loss if you meet one of two criteria